Dr. Judy Chou in

Dr. Judy Chou

Login to view DISC.
President, Chief Executive Officer, and Board Member at AltruBio Inc.
📍 San Francisco, California, United States

Dr. Judy Chou is the President and CEO of AltruBio, leading the development of therapies for autoimmune diseases. With over 25 years in biotech, she has held senior roles at Bayer, Pfizer, and Genentech. Dr. Chou earned her Ph. D. from Yale University and was a research faculty member at Harvard Medical School.

Dr. Chou is passionate about advancing science and bringing innovative treatments to patients. She enjoys mentoring and is a recognized leader, named one of the Most Influential Women in Business by the San Francisco Business Times and a top woman in biopharma by Endpoints News.

Her first project in the industry was as a BLA co-author for Humira, now one of the worlds best-selling drugs.

Read the full overview →
Experience
3 Years
Current Role
President, Chief Executive Officer, and Board Member
Job Level
Leadership
Location
San Francisco, California, United States
Personality Overview

How Dr. shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Dr. cares about

Immunological Diseases
As CEO of AltruBio, she is focused on developing novel therapeutics for autoimmune and inflammatory diseases, a core part of her company's mission.
Women in Biopharma
She recently spoke on a panel, “Celebrating Women Leading Innovation in Biopharma, ” and was named one of the most influential women in the field.
+5 more topics Login to view topics
Career

Work history

President, Chief Executive Officer, and Board Member
AltruBio Inc.
9-2022
Governing Board Member
California Institute for Regenerative Medicine (CIRM)
Board Member
Akero Therapeutics
Global Head of Biotech & Senior Vice President, and Bayer Berkeley Site Head
Bayer Pharmaceuticals
Board Of Directors, Bayer Fund
Bayer Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Ph.D.
Yale University
Executive Education
Harvard Business School
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Dr.. Free, 10 seconds.